| 1 |
Abuzahra HM. Kirenol protects against oxidized low-density lipoprotein induced damages in endothelial cells. Braz J Biol 2024;84:e259421. [DOI: 10.1590/1519-6984.259421] [Reference Citation Analysis]
|
| 2 |
Paudel KR, Patel V, Vishwas S, Gupta S, Sharma S, Chan Y, Jha NK, Shrestha J, Imran M, Panth N, Shukla SD, Jha SK, Devkota HP, Warkiani ME, Singh SK, Ali MK, Gupta G, Chellappan DK, Hansbro PM, Dua K. Nutraceuticals and COVID-19: A mechanistic approach toward attenuating the disease complications. J Food Biochem 2022;46:e14445. [PMID: 36239436 DOI: 10.1111/jfbc.14445] [Reference Citation Analysis]
|
| 3 |
Chan Y, Singh SK, Gulati M, Wadhwa S, Prasher P, Kumar D, Kumar AP, Gupta G, Kuppusamy G, Haghi M, George Oliver BG, Adams J, Chellappan DK, Dua K. Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases. J Drug Deliv Sci Technol 2022;74:103541. [PMID: 35774068 DOI: 10.1016/j.jddst.2022.103541] [Reference Citation Analysis]
|
| 4 |
Mahaboob Ali AA, Bugarcic A, Naumovski N, Ghildyal R. Ayurvedic formulations: Potential COVID-19 therapeutics? Phytomed Plus 2022;2:100286. [PMID: 35474908 DOI: 10.1016/j.phyplu.2022.100286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 5 |
Paudel KR, Dua K, Panth N, Hansbro PM, Chellappan DK. Advances in research with rutin-loaded nanoformulations in mitigating lung diseases. Future Med Chem 2022. [PMID: 35876083 DOI: 10.4155/fmc-2022-0088] [Reference Citation Analysis]
|
| 6 |
Paudel KR, Panth N, Manandhar B, Singh SK, Gupta G, Wich PR, Nammi S, Macloughlin R, Adams J, Warkiani ME, Chellappan DK, Oliver BG, Hansbro PM, Dua K. Attenuation of Cigarette-Smoke-Induced Oxidative Stress, Senescence, and Inflammation by Berberine-Loaded Liquid Crystalline Nanoparticles: In Vitro Study in 16HBE and RAW264.7 Cells. Antioxidants 2022;11:873. [DOI: 10.3390/antiox11050873] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 7 |
Ahmad A. Pharmacological Strategies and Recent Advancement in Nano-Drug Delivery for Targeting Asthma. Life 2022;12:596. [DOI: 10.3390/life12040596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Manandhar B, Paudel KR, Panth N, Hansbro P, Oliver BG, Dua K. Applications of extracellular vesicles as a drug-delivery system for chronic respiratory diseases. Nanomedicine (Lond) 2022. [PMID: 35019729 DOI: 10.2217/nnm-2021-0384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Allam VSRR, Paudel KR, Gupta G, Singh SK, Vishwas S, Gulati M, Gupta S, Chaitanya MVNL, Jha NK, Gupta PK, Patel VK, Liu G, Kamal MA, Hansbro PM, Oliver BGG, Chellappan DK, Dua K. Nutraceuticals and mitochondrial oxidative stress: bridging the gap in the management of bronchial asthma. Environ Sci Pollut Res Int 2022;29:62733-54. [PMID: 35796922 DOI: 10.1007/s11356-022-21454-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 10 |
Gomez HM, Pillar AL, Brown AC, Kim RY, Ali MK, Essilfie AT, Vanders RL, Frazer DM, Anderson GJ, Hansbro PM, Collison AM, Jensen ME, Murphy VE, Johnstone DM, Reid D, Milward EA, Donovan C, Horvat JC. Investigating the Links between Lower Iron Status in Pregnancy and Respiratory Disease in Offspring Using Murine Models. Nutrients 2021;13:4461. [PMID: 34960012 DOI: 10.3390/nu13124461] [Reference Citation Analysis]
|
| 11 |
Paudel KR, Jha SK, Allam VSRR, Prasher P, Gupta PK, Bhattacharjee R, Jha NK, Vishwas S, Singh SK, Shrestha J, Imran M, Panth N, Chellappan DK, Ebrahimi Warkiani M, Hansbro PM, Dua K. Recent Advances in Chronotherapy Targeting Respiratory Diseases. Pharmaceutics 2021;13:2008. [PMID: 34959290 DOI: 10.3390/pharmaceutics13122008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
